The Defense Health Agency (DHA) awarded Leidos, Inc. a single-award $102 million Indefinite Delivery Contract (IDC) for Meeting, Programmatic, and Administrative Support Services (MPASS) for the Congressionally Directed Medical Research Programs (CDMRP) at Fort Detrick, MD. The contract has a period of performance through January 2028.
Under this IDC, Leidos has been awarded multiple task orders to provide a range of services supporting DHA's medical research initiatives, including vision setting, pre-application screening, programmatic review, and general program support for various research areas such as cancer, traumatic brain injury, psychological health, and rare diseases. The task orders have cost-plus-fixed-fee pricing structures and do not utilize any set-aside designations. Leidos' experience in areas like scientific research, program management, and IT modernization has enabled it to secure these contracts to assist the DHA in advancing critical medical research priorities.
Generated 9/7/24, 11:02 AM